ABH Healthcare's initial public offering concluded on Thursday, August 27, 2026, with the issue achieving 83% subscription by the final day. According to latest reports from LiveMint, the retail portion was subscribed at 73%, non-institutional investors at 49%, while the qualified institutional buyers (QIB) portion was oversubscribed at 8.37x. The company received bids for 28,59,600 shares against the total 34,29,600 shares on offer. As per LiveMint, the grey market premium (GMP) stands at ₹0, indicating shares were trading at the issue price of ₹102 with no premium or discount in the unofficial market. The IPO allotment is expected to be finalized on Friday, August 28, 2026, with shares scheduled to list on the NSE SME platform on Tuesday, September 1, 2026.
ABH Healthcare launched its initial public offering on Monday, August 24, 2026, through the NSE Emerge platform, targeting to raise ₹35 crore from the market. The issue price band has been fixed at ₹96 to ₹102 per equity share with a face value of ₹10 per share. The IPO comprises a fresh issue of 34,29,600 equity shares through the book-building process, with an application lot size of 1,200 equity shares. The issue includes a Market Maker Reservation of 1,72,800 equity shares, while the net issue to the public stands at 32,56,800 equity shares. LiveMint reports that Fedex Securities Pvt Ltd serves as the book-running lead manager, Bigshare Services Pvt Ltd as the registrar, and Rikhav Securities Ltd as the market maker for the IPO.
As reported by LiveMint, ABH Healthcare generated ₹54.85 crore in revenue from operations during FY26, with Internal Medicine & Critical Care contributing the highest at ₹26.74 crore (52.4% of total revenue). General surgery followed at ₹2.89 crore (5.35%), orthopedics, trauma & joint replacement at ₹2.74 crore (5.2%), and cardiology at ₹2.69 crore (5.1%). The company's pharmacy income increased significantly to ₹2.75 crore in FY26 from ₹1.74 crore in FY24, while laboratory billing income stood at ₹3.50 crore in FY26 compared with ₹3.87 crore in FY24. According to LiveMint, the company's consolidated revenue rose from ₹41.38 crore in FY24 to ₹52.51 crore in FY26, while profit after tax increased more than threefold to ₹5.64 crore from ₹1.66 crore during the same period. The company was incorporated in 2021 and operates as a 150-bed multi-speciality hospital offering services across 25 medical specialities.
According to the company's latest financial data, ABH Healthcare operated 135 beds as of FY26, including 70 ICU beds, 9 pediatric units, 7 emergency units, and 10 dialysis beds. The hospital's bed occupancy rate stood at 47% in FY26 compared with 49% in FY25 and 63% in FY24. Average revenue per occupied bed (ARPOB) increased to ₹19,992 in FY26 from ₹18,245 in FY25 and ₹17,808 in FY24. Average length of stay (ALOS) stood at 3.36 days in FY26. The hospital treated 6,387 in-patient discharges and recorded 53,212 out-patient consultations during FY26. As of June 30, 2026, the company employed 37 doctors and 101 nurses, with over 30% of doctors having been associated with the hospital for more than five years. The hospital's clinical services span cardiac sciences, neurology, minimally invasive spine and brain procedures, gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT and maxillofacial surgery.
As reported by LiveMint, ABH Healthcare plans to use ₹17 crore of the net proceeds towards debt repayment in part or in full, ₹5 crore to fund its working capital requirements, and the remaining balance will be used for inorganic growth through unidentified acquisitions and general corporate purposes. The company's payor mix in FY26 included government schemes contributing ₹26.74 crore (52.4% of revenue), insurance & TPAs contributing ₹4.86 crore (9.5%), and self-pay patients contributing ₹16.25 crore (31.8%). The hospital is empaneled with over 30 private and public health insurance companies and third-party administrators, and is also empaneled under major government healthcare schemes including the Ex-Servicemen Contributory Health Scheme (ECHS), Railways, Food Corporation of India (FCI), Bharat Sanchar Nigam Limited (BSNL) and Ayushman Bharat - Sarbat Sehat Bima Yojana (ABSSBY). According to LiveMint, Managing Director Saurabh Baghi stated that the company remains focused on strengthening clinical capabilities and enhancing patient care as it enters the next phase as a listed entity.
